BridgeMD
New treatment option for Graves Disease
Official title Impact of Thyroid Hormones on Human Glucose and Energy Metabolism
ClinicalTrials.gov ID: NCT07410637
What this study is testing
- What it's testing
- The goal of this clinical trial to clarify the impact of changes in thyroid hormone levels on glucose and lipid metabolism. Patients will be included in whom thyroid hormone levels are intentionally changed by treatment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- patients with initial diagnosis of graves disease OR
- patients with initial diagnosis of thyroid carcinoma
You likely can't join if
- contraindications for oral glucose tolerance test
- Diabetes mellitus
- Fasting glucose level ≥ 200 mg/dL
- Exogenous insulin administration with action at the time of the test
- Current disease with activation of stress hormones
- Post-aggressive metabolism
See the full eligibility criteria
- patients with initial diagnosis of graves disease OR
- patients with initial diagnosis of thyroid carcinoma
- contraindications for oral glucose tolerance test
- Diabetes mellitus
- Fasting glucose level ≥ 200 mg/dL
- Exogenous insulin administration with action at the time of the test
- Current disease with activation of stress hormones
- Post-aggressive metabolism
- Acute infectious disease
The study team makes the final eligibility decision.
Where it's taking place
- Ulm, Baden-Wurttemberg, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ulm, Baden-Wurttemberg, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.